PHK
HRMY icon

Point72 Hong Kong’s Harmony Biosciences HRMY Stock Holding History

Point72 Hong Kong’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,872
Closed -$319K – 653
2023
Q4 		$319K Buy
+9,872
New +$276K 0.02% 403
2022
Q2 		– Sell
-6,071
Closed -$295K – 2133
2022
Q1 		$295K Buy
+6,071
New +$248K 0.01% 844
2021
Q3 		– Sell
-374
Closed -$11K – 2193
2021
Q2 		$11K Buy
+374
New +$11.2K ﹤0.01% 1730

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Hong Kong's HRMY Position: Q1 2024 in Review

Point72 Hong Kong sold out of Harmony Biosciences (HRMY) in Q1 2024, closing a stake of 9,872 shares — an estimated $319K sold.

Point72 Hong Kong first reported a position in HRMY in Q2 2021 and held it in 3 quarters. The position peaked at $319K in Q4 2023. 208 funds tracked by Wall St. Rank hold HRMY as of Q1 2024.

  • Point72 Hong Kong reported no remaining Harmony Biosciences position as of Q1 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 9,872 Harmony Biosciences shares in Q1 2024, an estimated $319K.
  • Point72 Hong Kong first reported a position in Harmony Biosciences in Q2 2021 and held it in 3 quarters.
  • Point72 Hong Kong's Harmony Biosciences position peaked at $319K in Q4 2023.
  • 208 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2024.

Based on Point72 Hong Kong's 13F filing for Q1 2024, filed 15 May 2024.